Schlemmer S R, Sirotnak F M
Program in Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, Graduate School of Medical Sciences, Cornell University, New York, New York 10021, USA.
Anal Biochem. 1995 Jul 1;228(2):226-31. doi: 10.1006/abio.1995.1343.
A reasonably facile and effective procedure is described for the preparation of inside-out plasma membrane vesicles from tumor cells. The method incorporates nitrogen cavitation, optimized with respect to the applied N2 pressure, in the absence of added divalent cations followed by differential centrifugation and discontinuous, sucrose gradient centrifugation. With the three tumor cell types utilized, multidrug-resistant (MEL/VCR-6) and parental (MEL/O) murine erythroleukemia cells and methotrexate-resistant (L1210/R24) L1210 leukemia cells, yields were in the range of 8-12 mg of plasma membrane vesicles/10(10) cells at a purity of 87-94% with average inside-out sidedness among preparations varying from 65 to 93% depending upon the cell type. Inside-out plasma membrane vesicles so derived were capable of sustaining ATP-dependent transport inward of two common antitumor cytotoxic agents, vinblastine and methotrexate. The former was demonstrated with inside-out vesicles from only P-glycoprotein-overexpressing, multidrug-resistant MEL/VCR-6 cells, while the latter was readily demonstrated in inside-out vesicles from all three cell types.
本文描述了一种从肿瘤细胞制备内翻式质膜囊泡的简便有效方法。该方法包括在不添加二价阳离子的情况下,对施加的氮气压力进行优化的氮空化处理,随后进行差速离心和不连续蔗糖梯度离心。在所使用的三种肿瘤细胞类型中,即多药耐药(MEL/VCR-6)和亲本(MEL/O)小鼠红白血病细胞以及甲氨蝶呤耐药(L1210/R24)L1210白血病细胞,产量为每10¹⁰个细胞8-12mg质膜囊泡,纯度为87-94%,不同细胞类型的制剂中平均内翻式取向率在65%至93%之间。由此获得的内翻式质膜囊泡能够维持两种常见抗肿瘤细胞毒性药物长春碱和甲氨蝶呤的ATP依赖性向内转运。前者仅在过表达P-糖蛋白的多药耐药MEL/VCR-6细胞的内翻式囊泡中得到证实,而后者在所有三种细胞类型的内翻式囊泡中都很容易得到证实。